瑞典全国队列研究中第二原发肺癌的增加
该研究基于瑞典全国癌症登记处1961至2021年数据,共识别853例第二原发肺癌(SPLC)。结果显示SPLC发病率自1980年起几乎线性增加,男女及各主要组织学类型间趋势相似。女性首癌为腺癌后10年累积概率最高(0.019),男性相对风险低于女性。年轻发病腺癌患者相对风险显著升高。
要点
- SPLC发病率自1980年起持续增加,男女趋势相似
- 女性首癌为腺癌者10年累积概率最高(0.019)
- 55岁前诊断女性腺癌患者相对风险达9.95
核心结论
- SPLC虽仍罕见,但数量快速增长,相对风险显著,提示对高危患者(如早发腺癌)应考虑CT筛查
研究设计与样本
- 全国性癌症登记队列研究,覆盖1961至2021年
- 共识别853例SPLC
主要发现
- SPLC发病率自1980年起几乎线性增加
- 组织学分布:腺癌63.9%,鳞癌19.4%,小细胞癌9.6%,大细胞癌9.1%
- 女性首癌为腺癌后10年累积概率0.019,鳞癌0.015,小细胞和大细胞癌均为0.008
- 男性对应累积概率分别为0.013、0.012、0.002和0.005
- SPLC相对风险总体为3.59,女性4.16,男性2.99
关键数值与推荐
- 腺癌后SPLC累积概率:女性0.019,男性0.013(10年)
- 鳞癌后:女性0.015,男性0.012
- 小细胞癌后:女性0.008,男性0.002
- 大细胞癌后:女性0.008,男性0.005
- 55岁前女性腺癌相对风险9.95,男性6.77
临床怎么用
- 对早发腺癌(尤其女性)患者,可考虑纳入CT筛查计划以早期发现SPLC
- 不同组织学类型后的SPLC组织学多样,需保持警惕
局限性
- SPLC总体仍属罕见事件
- 研究基于瑞典人群,外推需谨慎
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background We describe the occurrence of second primary lung cancers (SPLCs) and their determinant in Sweden. Methods Nation-wide cancer registry from years 1961 to 2021 identified a total of 853 SPLCs. Results The incidence of SPLCs increased almost linearly from 1980 onwards, equally for women and men and approximately equally after the four main histological types. SPLC included adenocarcinoma 63.9%, squamous cell carcinoma (SCC) 19.4%, small cell carcinoma 9.6% and large cell carcinoma 9.1%. The female cumulative probability (CumP) of SPLC after first adenocarcinoma in 10 years reached 0.019, after SCC 0.015 and after small and large cell carcinoma 0.008. The respective CumP for men was 0.013, 0.012, 0.002 and 0.005. While adenocarcinoma was often followed by second adenocarcinoma, after first non-adenocarcinoma SPLCs presented in diverse histologies. Relative risk of SPLC compared with first lung cancer was overall 3.59, higher for women (4.16) than for men (2.99) and approximately equally high after adenocarcinoma and SCC. In patients diagnosed before age 55 years, the relative risk was 6.68 for all, but after female adenocarcinoma it was 9.95 compared with 6.77 for males. The highest relative risks, up to 20-fold, were found after early onset female adenocarcinoma diagnosed after defined T stages. Conclusions Although SPLCs are still rare, their number is increasing rapidly and the relative risks compared with first lung cancer are substantial, qualifying selected groups of high-risk patients, such as patients with early onset adenocarcinoma for early detection by CT screening when/if such tests become available.
引用
- Thorax:Increase in second primary lung cancers in a nation-wide cohort study from Sweden
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。